INVACARE CORP 4
4 · INVACARE CORP · Filed Jul 1, 2013
Insider Transaction Report
Form 4
Gudbranson Robert K
Sr. VP and CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2013-03-18+7,500→ 169,300 totalExercise: $14.49From: 2015-03-31Exp: 2023-03-18→ Common Shares (7,500 underlying) - Award
Employee Stock Option (Right to Buy)
2013-03-18+7,500→ 161,800 totalExercise: $14.49From: 2014-03-31Exp: 2023-03-18→ Common Shares (7,500 underlying) - Award
Common Shares
2013-03-18+5,800→ 38,080 total - Award
Employee Stock Option (Right to Buy)
2013-03-18+7,500→ 176,800 totalExercise: $14.49From: 2016-03-31Exp: 2023-03-18→ Common Shares (7,500 underlying) - Award
Employee Stock Option (Right to Buy)
2013-03-18+7,500→ 184,300 totalExercise: $14.49From: 2017-03-31Exp: 2023-03-18→ Common Shares (7,500 underlying)
Footnotes (2)
- [F1]Restricted shares granted pursuant to the Invacare Corporation 2003 Performance Plan in an exempt transaction under Rule 16b-3. These shares vest in 25% increments over four years commencing on May 15, 2014.
- [F2]The reporting person holds previously reported options to buy 154,300 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between April 1, 2008 and August 14, 2012, at exercise prices between $13.37 and $25.79 per share, will expire between April 1, 2018 and August 14, 2022 and became or will become exercisable between March 31, 2009 and September 30, 2016.